Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma
Latest Information Update: 11 May 2023
At a glance
- Drugs Cabozantinib (Primary)
- Indications Merkel cell carcinoma
- Focus Therapeutic Use
- 13 Jul 2022 Planned primary completion date changed from 1 Jun 2022 to 1 Dec 2022.
- 21 Mar 2022 Planned primary completion date changed from 1 Dec 2021 to 1 Jun 2022.
- 11 Nov 2020 Planned End Date changed from 1 Jan 2021 to 1 Dec 2022.